525 related articles for article (PubMed ID: 34356638)
1. Prion-Like Proteins in Phase Separation and Their Link to Disease.
Sprunger ML; Jackrel ME
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356638
[TBL] [Abstract][Full Text] [Related]
2. Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation.
Agarwal A; Mukhopadhyay S
J Mol Biol; 2022 Jan; 434(1):167368. PubMed ID: 34808226
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
5. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
6. How Do Yeast Cells Contend with Prions?
Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635197
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
[TBL] [Abstract][Full Text] [Related]
8. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
9. Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion.
Agarwal A; Arora L; Rai SK; Avni A; Mukhopadhyay S
Nat Commun; 2022 Mar; 13(1):1154. PubMed ID: 35241680
[TBL] [Abstract][Full Text] [Related]
10. Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior.
Franzmann TM; Alberti S
J Biol Chem; 2019 May; 294(18):7128-7136. PubMed ID: 29921587
[TBL] [Abstract][Full Text] [Related]
11. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.
March ZM; King OD; Shorter J
Brain Res; 2016 Sep; 1647():9-18. PubMed ID: 26996412
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid actions on abnormal protein aggregation, phase transitions and phase separation.
Silva JL; Vieira TC; Cordeiro Y; de Oliveira GAP
Curr Opin Struct Biol; 2022 Apr; 73():102346. PubMed ID: 35247749
[TBL] [Abstract][Full Text] [Related]
13. A Hybrid Model to Study Amyloid Cross-Toxicity.
Henriquez G; Mendez L; Narayan M
ACS Chem Neurosci; 2020 Feb; 11(3):228-230. PubMed ID: 31920071
[TBL] [Abstract][Full Text] [Related]
14. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
Sengupta I; Udgaonkar JB
Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
[TBL] [Abstract][Full Text] [Related]
15. The protonation state of histidine 111 regulates the aggregation of the evolutionary most conserved region of the human prion protein.
Fonseca-Ornelas L; Zweckstetter M
Protein Sci; 2016 Aug; 25(8):1563-7. PubMed ID: 27184108
[TBL] [Abstract][Full Text] [Related]
16. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
17. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
18. Phase separation of a yeast prion protein promotes cellular fitness.
Franzmann TM; Jahnel M; Pozniakovsky A; Mahamid J; Holehouse AS; Nüske E; Richter D; Baumeister W; Grill SW; Pappu RV; Hyman AA; Alberti S
Science; 2018 Jan; 359(6371):. PubMed ID: 29301985
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity to prions: anti-prion systems turn a tsunami of prions into a slow drip.
Wickner RB; Edskes HK; Son M; Wu S; Niznikiewicz M
Curr Genet; 2021 Dec; 67(6):833-847. PubMed ID: 34319422
[TBL] [Abstract][Full Text] [Related]
20. Aberrant liquid-liquid phase separation and amyloid aggregation of proteins related to neurodegenerative diseases.
Ahmad A; Uversky VN; Khan RH
Int J Biol Macromol; 2022 Nov; 220():703-720. PubMed ID: 35998851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
